Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440).
Stilgenbauer S, Morschhauser F, Wendtner CM, Cartron G, Hallek M, Eichhorst B, Kozloff MF, Giever T, Lozanski G, Jiang Y, Huang H, Pignataro DS, Schary W, Humphrey K, Mobasher M, Salles G.
Stilgenbauer S, et al. Among authors: hallek m.
Haematologica. 2021 Nov 1;106(11):2834-2844. doi: 10.3324/haematol.2020.261107.
Haematologica. 2021.
PMID: 33121235
Free PMC article.
Clinical Trial.